Tumanda, Antonieta .

HRN: 25-94-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2024
CEFTRIAXONE 1G (VIAL)
09/25/2024
10/02/2024
IV
1g
Q12
Pneumonia
Waiting Final Action 
09/28/2024
MUPIROCIN 2%, 15G (TUBE)
09/28/2024
10/05/2024
TOPICAL
Apply Thinly
Bid
Pressure Ulcer
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: